Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Pharmacists play a crucial role in patient education and personalized care.

Tailored medication preparation and ongoing education are crucial for effective treatments.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

Pharmacists play a crucial role in patient care and education.

Finasteride improves hair density and thickness in women with hair loss.

Dutasteride safely treats hair loss without harming sexual function.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Alternative medicine lacks scientific support and relies on the placebo effect, but remains popular and integrated into German healthcare.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

PRP is more effective than minoxidil and placebo for treating hair loss.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.